LYRA
Lyra Therapeutics, Inc.
Latest Form 4:Sale$6KbyPalasis Maria (President & CEO) · filed Jan 8, 2026
Lyra Therapeutics, Inc. (LYRA) has 7 SEC Form 4 filings (17 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: May 15, 2026.
The most active filer is 10% Owner PERCEPTIVE ADVISORS LLC with 6 filings.
- Industry:Biotechnology
- CEO:Carmichael S. Roberts Jr.
- Employees:30
- HQ:Watertown, MA, US
- IPO:2020-05-01
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$535K
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
Market Cap
$444K
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| President & CEO | Sale | 1,702 | $6K | Jan 8 | SEC ↗ | |
Cavalier JasonFirst filing | Chief Financial Officer | Sale | 769 | $3K | Jan 8 | SEC ↗ |
| 10% Owner | Sale | 5,320 | $23K | Nov 13 | SEC ↗ | |
| 10% Owner | Sale | 8,745 | $35K | Nov 13 | SEC ↗ | |
| 10% Owner | Sale | 31,810 | $124K | Nov 13 | SEC ↗ | |
PERCEPTIVE ADVISORS LLCFirst filing | 10% Owner | Sale | 32,149 | $167K | Nov 10 | SEC ↗ |
PERCEPTIVE ADVISORS LLCFirst filing | 10% Owner | Sale | 19,739 | $94K | Nov 10 | SEC ↗ |
PERCEPTIVE ADVISORS LLCFirst filing | 10% Owner | Sale | 18,502 | $84K | Nov 10 | SEC ↗ |
Related companies
Lyra Therapeutics, Inc. is in the Healthcare sector.